Email Page Print Page

News & Media

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released via email or RSS.

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011

2015 Archives

Dec 18, 2015
Clonidine Topical Gel clinical trial for the treatment of painful diabetic neuropathy underway
Dec 3, 2015
Managed Similar Function at Salix Pharmaceuticals for Past 14 Years
Nov 9, 2015
Company to host conference call today at 8:00 AM ET
Sep 8, 2015
As of October 1, all patients presenting a buprenorphine/naloxone prescription will receive BUNAVAIL
Aug 13, 2015
Approval of new formulation expected to allow ONSOLIS to return to U.S. market in 2016
Aug 12, 2015
Plesha to Lead BUNAVAIL Sales Effort; Joins BDSI Following 13 years in Building and Managing the Salix GI Sales Force
Aug 10, 2015
BUNAVAIL® (buprenorphine and naloxone) buccal film prescriptions grow 27% over first quarter; addition of over 680 new prescribers
Jul 14, 2015
Joins BDSI following 8 years in similar role at Salix Pharmaceuticals
Jun 8, 2015
Recent Salix Counsel Takes Over General Counsel Role at BDSI
Jun 1, 2015
Non-dilutive proceeds to further support the ongoing launch of BUNAVAIL
May 28, 2015
Experienced New Hires Add Key Support to the BUNAVAIL launch